Surface functionalization of silica nanoparticles with cysteine: a low-fouling zwitterionic surface.

Herein, we report on the functionalization of silica nanoparticles with a small molecule, the amino acid cysteine, in order to create a low-fouling zwitterionic surface for nanomedicine applications. The cysteine functionalization was shown to impart the particles with excellent stability in both salt and single-protein solutions of lysozyme (positively charged) and bovine serum albumin (negatively charged). Bare silica particles precipitated immediately in a lysozyme solution, while cysteine-functionalized particles were stable for 20 h. Furthermore, the particles displayed excellent long-term stability in solutions of human serum showing no aggregation over a period of 14 days. The functionalized particles also possess multiple reactive surface groups for further coupling reactions. We believe that the surface functionalization schemes described in this report represent a versatile and effective method of stabilizing nanoparticle systems in biological media for their use in a variety of therapeutic and diagnostic applications.

[1]  Ameena Meerasa,et al.  CH(50): a revisited hemolytic complement consumption assay for evaluation of nanoparticles and blood plasma protein interaction. , 2011, Current drug delivery.

[2]  Luxiang Wang,et al.  Superhydrophobicity of silica nanoparticles modified with polystyrene , 2011 .

[3]  J. Schlenoff,et al.  Zwitterion-stabilized silica nanoparticles: toward nonstick nano. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[4]  Wenping Wang,et al.  A facile strategy to modify TiO2 nanoparticles via surface‐initiated ATRP of styrene , 2010 .

[5]  Mark E. Davis,et al.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles , 2010, Nature.

[6]  Q. Wei,et al.  Zwitterionic phosphorylcholine as a better ligand for gold nanorods cell uptake and selective photothermal ablation of cancer cells. , 2010, Chemical communications.

[7]  Ramón Torrecillas,et al.  Nanotechnology in joint replacement. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[8]  Shaoyi Jiang,et al.  Novel zwitterionic-polymer-coated silica nanoparticles. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[9]  Mauro Ferrari,et al.  Nanomedicine--challenge and perspectives. , 2009, Angewandte Chemie.

[10]  K. Furic,et al.  DFT study of molecular structure and vibrations of 3-glycidoxypropyltrimethoxysilane. , 2008, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[11]  Robert Langer,et al.  Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticles , 2008, Proceedings of the National Academy of Sciences.

[12]  Robert Langer,et al.  New opportunities: the use of nanotechnologies to manipulate and track stem cells. , 2008, Cell stem cell.

[13]  Wenjun Zhao,et al.  Bioconjugated silica nanoparticles: Development and applications , 2008 .

[14]  Jia-cong Shen,et al.  Zwitterionic phosphorylcholine as a better ligand for stabilizing large biocompatible gold nanoparticles. , 2008, Chemical communications.

[15]  R. Langer,et al.  Intracellular delivery of core-shell fluorescent silica nanoparticles. , 2008, Biomaterials.

[16]  Shaoyi Jiang,et al.  An New Avenue to Nonfouling Materials , 2008 .

[17]  M. Bawendi,et al.  Compact cysteine-coated CdSe(ZnCdS) quantum dots for in vivo applications. , 2007, Journal of the American Chemical Society.

[18]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[19]  Jackie Y. Ying,et al.  Synthesis of water-soluble and functionalized nanoparticles by silica coating , 2007 .

[20]  Kemin Wang,et al.  Dye-doped nanoparticles for bioanalysis , 2007 .

[21]  Robert Langer,et al.  Targeted nanoparticles for cancer therapy , 2007 .

[22]  Andrew A. Burns,et al.  Fluorescent core-shell silica nanoparticles: towards "Lab on a Particle" architectures for nanobiotechnology. , 2006, Chemical Society reviews.

[23]  Weihong Tan,et al.  Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[24]  S. A. Gómez-Lopera,et al.  Colloidal stability of magnetite/poly(lactic acid) core/shell nanoparticles. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[25]  Weihong Tan,et al.  Watching Silica Nanoparticles Glow in the Biological World , 2006 .

[26]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.

[27]  Shaoyi Jiang,et al.  Strong resistance of phosphorylcholine self-assembled monolayers to protein adsorption: insights into nonfouling properties of zwitterionic materials. , 2005, Journal of the American Chemical Society.

[28]  Kazuhiko Ishihara,et al.  Phosphorylcholine-containing polymers for biomedical applications , 2005, Analytical and bioanalytical chemistry.

[29]  L. Hench,et al.  Tailoring of bioactive glasses for the release of nitric oxide as an osteogenic stimulus , 2004 .

[30]  P. Caliceti,et al.  Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates. , 2003, Advanced drug delivery reviews.

[31]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[32]  M. W. Daniels,et al.  Use of (Glycidoxypropyl)trimethoxysilane as a Binder in Colloidal Silica Coatings , 1997 .

[33]  T. J. Horr,et al.  The reactions of 3-glycidoxypropyltrimethoxysilane in acidic solutions on polymerization and in the presence of silica , 1997 .

[34]  C. Cazé,et al.  Synthesis of macromolecular coupling agents and binders , 1992 .

[35]  H. Susi,et al.  Vibrational analysis of amino acids: cysteine, serine, β-chloroalanine , 1983 .